We demonstrated the presence of CTCs carrying oncogenic EWS–FLI1/ERG fusions in only 19 % (n = 3) of ES patients with confirmed EWS/FLI1 rearrangements in tumor specimen. This evidence concerns the gene EWSR1 and Ewing sarcoma.